Deutsche Bank analyst Justin Bowers upgrades Repligen (NASDAQ:RGEN) from Hold to Buy and lowers the price target from $180 to $155.
Deutsche Bank Upgrades Repligen to Buy, Lowers Price Target to $155
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.